Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: Belagenpumatucel L
Description: A TGF-beta2 antisense gene-modified allogeneic tumor cell vaccine that inhibits TGF-beta2; in phase II clinical trials for treatment of non-small-cell lung cancer. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Jun 2019